Digital CBT-I Still Works After 2 Years: The Longest Follow-Up Yet

A new RCT in The Lancet finds fully automated digital CBT for insomnia remains clinically and cost-effective at 2 years, with sustained sleep improvements and lower healthcare costs.

3 min read

TL;DR

Fully automated digital CBT-I maintained clinically meaningful improvements in insomnia severity at 2-year follow-up, and was cost-effective compared to online patient education alone.

If you've ever wondered whether a fully automated sleep program — no therapist, no face-to-face sessions — can actually fix chronic insomnia in the long run, this is the study you've been waiting for.

Published in The Lancet Regional Health – Europe, this 2-year follow-up of a single-blind, superiority RCT tracked 1,721 adults with significant insomnia symptoms (Insomnia Severity Index ≥ 12) across Norway. Half got a fully automated digital CBT-I program called SHUTi. The other half got a well-designed online patient education module as a control.

The headline: At 2 years, the dCBT-I group still reported meaningfully lower insomnia severity scores compared to the education group. Not just statistically significant — clinically significant. And the cost analysis? The digital program saved the healthcare system money over the 2-year horizon.

What makes this study different

Most digital sleep intervention studies stop at 6 or 12 months. A 2-year follow-up with >80% retention is rare. The intervention was fully automated — no therapist check-ins, no human touch points. Just a structured, evidence-based program delivered through a web browser.

The participants were self-referred — meaning real people who wanted help, not a recruited lab sample. That makes the results more generalizable to what happens when someone googles "help for insomnia" and clicks on a digital health product.

The money question

The cost-effectiveness piece is the standout finding here. When you factor in healthcare utilization savings over 2 years, the digital program actually cost less from a societal perspective than the education control. That flips the usual narrative that "good sleep care is expensive."

What this means for you

If you're struggling with sleep and thinking about trying a digital CBT-I program:

  • It's not a quick fix. The study measured outcomes at 2 years. Real change takes time.
  • Self-guided works. You don't need a therapist for CBT-I to be effective. The structured curriculum does the heavy lifting.
  • Consistency matters more than perfection. The program worked through gradual habit restructuring, not overnight transformation.

Practical tips

  1. Look for dCBT-I programs that cover the core components: stimulus control, sleep restriction, cognitive restructuring, and sleep hygiene.
  2. Stick with it for at least 8 weeks before judging effectiveness.
  3. Track your Insomnia Severity Index (free online) as a benchmark — a drop of 6+ points is considered clinically meaningful.

Related reading from SleepFold

FAQ

Q: Is digital CBT-I as effective as in-person therapy? A: The evidence suggests comparable outcomes for uncomplicated insomnia. In-person therapy may still be better for complex cases with comorbid conditions.

Q: How much does a dCBT-I program cost? A: Programs range from $40–$150 for a complete course. Many are now covered by insurance or employer wellness programs.

Q: Can I use it if I'm already on sleep medication? A: Yes, but talk to your doctor. dCBT-I can help reduce medication dependency over time, but you shouldn't stop prescription sleep aids abruptly.


Reference: Vethe D, Khan ZA, Vestergaard CL, et al. Long-term clinical and cost-effectiveness of a fully automated digital cognitive behavioural therapy for insomnia: 2-year follow-up of a single-blind, superiority, randomised controlled trial. Lancet Reg Health Eur. 2026. DOI: 10.1016/j.lanepe.2026.101691

References

  1. [1]https://doi.org/10.1016/j.lanepe.2026.101691

Frequently Asked Questions

The evidence suggests comparable outcomes for uncomplicated insomnia. In-person therapy may still be better for complex cases with comorbid conditions.

Related Topics